Umoja Biopharma

Umoja Biopharma is developing a new cancer treatment method that re-equips the patient's immune system in vivo, enhancing the body's natural ability to fight cancer. We hope that all cancer patients will have the opportunity to access the most advanced immunotherapy without being limited by traditional cancer treatments. By combining an in-depth understanding of immune physiology and genetic engineering with the most advanced and integrated cellular immunotherapy platform for cancer treatment currently under development, we aim to transform the future of cancer therapy.